---
figid: PMC4530463__nihms628769f1
figlink: /pmc/articles/PMC4530463/figure/F1/
number: F1
caption: The IL-17 receptor complex (IL-17RA/IL-17RC) is ubiquitously expressed and
  its ligands include IL-17A and IL-17F homodimers, as well as IL-17A/F heterodimers.
  Ligand-induced IL-17 receptor signaling initiates the recruitment of the essential
  adaptor molecule Act1, which in turn recruits tumor necrosis factor-R-associated
  factor 6 (TRAF6), a critical upstream activator of the NF-κB pathway. Specifically,
  TRAF6 recruits the kinase TAK1 and its binding partners TAB2 and TAB3 leading to
  activation of the inhibitor of NF-κB kinase (IKK) complex and thereby to induction
  of NF-κB translocation. It is uncertain whether TRAF6 is also required for the activation
  of mitogen-activated protein kinases (MAPKs) that link IL-17 receptor signaling
  to activation of the transcription factor activator protein-1. Interleukin-17 receptor
  activation also induces the recruitment of the IKK-related kinase IKKi to the IL-17
  receptor–Act1 complex. IKKi phosphorylates Act1 generating a docking site for recruitment
  of TRAF2 and TRAF5. The resulting Act1-TRAF2-TRAF6 complex sequesters splicing factor
  SF2 resulting in mRNA stabilization of target genes (e.g., chemokines). Another
  important transcription factor activated downstream of Act1 is CCAAT/enhancer-binding
  protein (C/EBP). The activation of NF-κB, transcription factor activator protein-1,
  and C/EBP (C/EBPβ and C/EBPδ) leads to the induction of genes encoding for inflammatory
  mediators and neutrophil-specific CXC chemokines (e.g., CXCL8), antimicrobial peptides,
  and the osteoclastogenic factor RANKL. Tumor necrosis factor signaling can synergize
  with IL-17 signaling through C/EBP to amplify inflammatory mediators such as IL-6
  and CXCL8. Drawn on the basis of information from several sources (, , , ).
pmcid: PMC4530463
papertitle: Basic biology and role of interleukin-17 in immunity and inflammation.
reftext: Camille Zenobia, et al. Periodontol 2000. ;69(1):142-159.
pmc_ranked_result_index: '109851'
pathway_score: 0.9689284
filename: nihms628769f1.jpg
figtitle: Basic biology and role of interleukin-17 in immunity and inflammation
year: ''
organisms:
- Homo sapiens
ndex: 4352ab7c-decb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4530463__nihms628769f1.html
  '@type': Dataset
  description: The IL-17 receptor complex (IL-17RA/IL-17RC) is ubiquitously expressed
    and its ligands include IL-17A and IL-17F homodimers, as well as IL-17A/F heterodimers.
    Ligand-induced IL-17 receptor signaling initiates the recruitment of the essential
    adaptor molecule Act1, which in turn recruits tumor necrosis factor-R-associated
    factor 6 (TRAF6), a critical upstream activator of the NF-κB pathway. Specifically,
    TRAF6 recruits the kinase TAK1 and its binding partners TAB2 and TAB3 leading
    to activation of the inhibitor of NF-κB kinase (IKK) complex and thereby to induction
    of NF-κB translocation. It is uncertain whether TRAF6 is also required for the
    activation of mitogen-activated protein kinases (MAPKs) that link IL-17 receptor
    signaling to activation of the transcription factor activator protein-1. Interleukin-17
    receptor activation also induces the recruitment of the IKK-related kinase IKKi
    to the IL-17 receptor–Act1 complex. IKKi phosphorylates Act1 generating a docking
    site for recruitment of TRAF2 and TRAF5. The resulting Act1-TRAF2-TRAF6 complex
    sequesters splicing factor SF2 resulting in mRNA stabilization of target genes
    (e.g., chemokines). Another important transcription factor activated downstream
    of Act1 is CCAAT/enhancer-binding protein (C/EBP). The activation of NF-κB, transcription
    factor activator protein-1, and C/EBP (C/EBPβ and C/EBPδ) leads to the induction
    of genes encoding for inflammatory mediators and neutrophil-specific CXC chemokines
    (e.g., CXCL8), antimicrobial peptides, and the osteoclastogenic factor RANKL.
    Tumor necrosis factor signaling can synergize with IL-17 signaling through C/EBP
    to amplify inflammatory mediators such as IL-6 and CXCL8. Drawn on the basis of
    information from several sources (, , , ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRAF3IP2
  - IL17F
  - IKBKB
  - CSF3
  - CHUK
  - JUNB
  - TNFRSF1A
  - EBP
  - CXCL1
  - CXCL2
  - IKBKG
  - CXCL3
  - TRAF2
  - TRAF5
  - FOSL1
  - FOS
  - FOSB
  - JUN
  - CXCL11
  - JUND
  - CXCL14
  - CXCL13
  - SRSF1
  - TAB2
  - CXCL8
  - CXCL10
  - CXCL9
  - PF4
  - PPBP
  - FOSL2
  - IKBKE
  - IL17RA
  - IL17RC
  - NFKB1
  - TNFSF11
  - CXCL6
  - TRAF6
  - TNF
  - CXCL5
  - CXCL12
  - IL17A
genes:
- word: Act1
  symbol: ACT1
  source: hgnc_alias_symbol
  hgnc_symbol: TRAF3IP2
  entrez: '10758'
- word: IL-17F
  symbol: IL-17F
  source: hgnc_alias_symbol
  hgnc_symbol: IL17F
  entrez: '112744'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: G-CSF
  symbol: G-CSF
  source: hgnc_prev_symbol
  hgnc_symbol: CSF3
  entrez: '1440'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: C/EBP
  symbol: EBP
  source: hgnc_symbol
  hgnc_symbol: EBP
  entrez: '10682'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF5
  symbol: TRAF5
  source: hgnc_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: •G-CSF
  symbol: G-CSF
  source: hgnc_prev_symbol
  hgnc_symbol: CSF3
  entrez: '1440'
- word: SF2
  symbol: SF2
  source: hgnc_alias_symbol
  hgnc_symbol: SRSF1
  entrez: '6426'
- word: TAB2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: IKKI
  symbol: IKK-i
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: IL-17RA
  symbol: IL-17RA
  source: hgnc_alias_symbol
  hgnc_symbol: IL17RA
  entrez: '23765'
- word: IL-17RC
  symbol: IL17RC
  source: hgnc_symbol
  hgnc_symbol: IL17RC
  entrez: '84818'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: •RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: IL-17A
  symbol: IL-17A
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
chemicals: []
diseases: []
figid_alias: PMC4530463__F1
redirect_from: /figures/PMC4530463__F1
figtype: Figure
---
